Press Releases

INDIANAPOLIS, Jan. 30, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced financial results for the fourth quarter and full year of 2019.

INDIANAPOLIS, Jan. 30, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Incyte (NASDAQ: INCY) announced today that baricitinib met the primary endpoint in BREEZE-AD5, an investigational Phase 3, randomized, placebo-controlled study evaluating the safety and efficacy of baricitinib for the treatment of adult patients with moderate to severe atopic dermatiti

NEW YORK, Jan. 30, 2020 /PRNewswire/ -- Inspired by the Ebola outbreak of '14, then Prof. Tim Johnson and son David co-founded Infrared Medical Technologies, LLC (IMT) to develop ThermoWand®, a long range medical grade thermometer. Now Dr. Johnson has also been awarded Patent #10502629 B2 for Temperature Measurement by Infrared Ana

PLYMOUTH MEETING, Pa., Jan. 30, 2020 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) today announced that it is collaborating with Beijing Advaccine Biotechnology Co. to advance the development in China of INO-4800, Inovio's vaccine against the recently emerged strain of coronavirus (2019-nCoV) that has killed numerous peo

WASHINGTON, Jan. 30, 2020 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) (the "Company") today announced results for the fourth quarter and full year 2019.  All results in this release reflect only continuing operations unless otherwise noted.For the quarter ended December 31, 2019, net earnings were $792.

CAMBRIDGE, Mass., Jan. 30, 2020 /PRNewswire/ -- Synlogic, Inc., (Nasdaq: SYBX) a clinical stage company applying synthetic biology to beneficial microbes to develop novel, living medic

EXTON, Pa., Jan. 30, 2020 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today

WALTHAM, Mass., Jan. 30, 2020 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the fourth quarter and full year ended December 31, 2019. Fourth Quarter and Full Year 2019 HighlightsFourth quarter revenue increase

MINNEAPOLIS, Jan. 30, 2020 /PRNewswire/ -- Excelera®, the company behind the Excelera Network, today announced the appointment of Meredith Holt as National Vice President of Sales. In this role, Holt will drive Excelera's business success and expansion by implementing a strong and sustainable health system partnership strategy, includin

UPPSALA, Sweden, Jan. 30, 2020 /PRNewswire/ --Q4 2019 highlights            Total net revenues of SEK 238.1 million (227.1), up 4.8 percent            Zubsolv® US net revenues